Downloadable

Effectiveness of CGM in Older Adults Infographic

Evaluation of CGM in older adults with type 2 diabetes on basal insulin: post-hoc analysis of MOBILE study.

View Infographic
Effectiveness of CGM in Older Adults with T2D Treated with Basal Insulin
Publication Date June 24, 2026
Content category
Guidelines & Research
Clinical focus
Type 2 Diabetes

This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care.

Evidence summaries for real-world care

Effectiveness of CGM in Older Adults Infographic

Download for easy reference, printing, or sharing with your care team.

References

  1. Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technol Ther. 2022;24(5):299-306. doi:10.1089/dia.2021.0494 
  2. Martens T, Beck RW, et al; MOBILE Study Group. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA. 2021;325(22):2262-2272. doi:10.1001/jama.2021.7444

Related Resources

icon-research-spotlight
Downloadable

CGM in Type 2 Diabetes Infographic

Evidence from three studies on CGM in type 2 diabetes, highlighting outcomes relevant to primary care.
Real-Time Real Talk Logo
Podcast

How CGM Can Improve Patient Outcomes in Type 2 Diabetes

Clinical perspectives on using CGM to guide day‑to‑day decisions in type 2 diabetes.
CGM Frequency and Glycemic Control in People with T2D - 1200x1200
Downloadable

CGM Frequency & Glycemic Control in Type 2 Diabetes Infographic

This infographic shows how longer and more consistent CGM use leads to improved A1C in people with type 2 diabetes.
Exploring the Impact of CGM Infographic - 1200x1200
Downloadable

Impact of CGM on Perceived Control of Type 2 Diabetes Infographic

This study aims to understand how CGM use relates to psychosocial benefits in patients with non-intensive insulin treated diabetes .
MAT-15116